Biogen CMO Says Company Plans To Hire 150 For Neuroscience Development

Now that Pfizer (PFE) and Allergan (AGN) are going to merge, the two companies’ leaders are trying to explain, or perhaps justify, the rationale behind the merger. Cambridge, Mass.-based Biogen, Inc. (BIIB) indicated at the J.P. Morgan Healthcare Conference in San Francisco that it plans to hire 150 new employees. This is something of a surprise after the company’s October 2015 “Biogen Bombshell,” when the company announced it was laying off 11 percent of its staff and slashing several pipeline programs. That cut equaled 880 jobs. However, Al Sandrock, Biogen’s chief medical office, said at J.P. Morgan that the company plans to add staffers to its neuroscience development staff. When asked about the layoffs, he said, “That’s behind us. We’re on the cusp of breakthroughs on neuroscience.” There have been…


Link to Full Article: Biogen CMO Says Company Plans To Hire 150 For Neuroscience Development